57
Health & Science2h 42m ago

Germany's psilocybin compassionate use program is underway with early patient experiences and progress in securing insurance coverage.

Germany

Who
Lea Mertens, Andrea Jungaberle, Josh Hardman, OVID Clinic Berlin, Central Institute of Mental Health (CIMH) in Mannheim
What
Germany's psilocybin compassionate use program is underway with early patient experiences and progress in securing insurance coverage.
When
Tue, 16 Jun 2026 10:11:55 GMT · 2h 42m ago
Where
Germany ·
Why
Germany's medicines regulator green-lit a psilocybin compassionate use program last summer, the first such pathway in the European Union.
The Frontline Impact

How this affects you

This program offers a new pathway for patients with certain mental health conditions in Germany to access psilocybin treatment outside of clinical trials. Securing insurance coverage for these treatments could make them more accessible to a wider range of patients.

Story chain

4 events in this thread
  1. Currently Reading2h 42m ago
    Germany's psilocybin compassionate use program is underway with early patient experiences and progress in securing insurance coverage.
  2. Health & Science2h 42m ago
    Germany's medicines regulator green-lit a psilocybin compassionate use program, the first in the European Union.
    Open article
  3. Health & Science2h 42m ago
    Germany has green-lit the EU’s first psilocybin compassionate use program, with two centers, OVID Clinic Berlin and CIMH Mannheim, permitted to offer dosing.
    Open article
  4. Health & Science2h 42m ago
    Germany’s medicines regulator green-lit a psilocybin compassionate use program, the first such pathway in the European Union.
    Open article

Verified Sources & Citations

Credibility ratings reflect the AI ingestion pipeline's assessment of source provenance.